Neostigmine/Glycopyrrolate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Neostigmine/Glycopyrrolate, covering 2025-08-26 to 2025-08-26. Get the full timeline:
Most recent: Clinical Trial Update: Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in Elderly Patients [Phase 4]